single.php FIREFISH trial of risdiplam – Lay summary | SMA Europe

Single

Comments Off on FIREFISH trial of risdiplam – Lay summary

This document provides a summary of the 12-month results of Parts 1 and 2 of the FIREFISH study. The study started in December 2016 and met its key endpoints in November 2019, when the last baby to take part had completed 12 months of treatment with risdiplam, the drug being investigated in this study. The study will continue up to 5 years after the last baby has enrolled in the study.